Syndax Pharmaceuticals Inc - COM (SNDX)

Historical Portfolio Holders from Q1 2016 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
88.9M
Holdings value Q3 2024
$1.71B
Value change Q3 2024
+$22.8M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
207
Number of buys Q3 2024
118
Number of sells Q3 2024
-81
Average buys Q3 2024 %
+0.002%
Average sells Q3 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 88.9M $1.71B +$22.8M $19.25 209
2024 Q2 87.3M $1.79B -$71.1M $20.53 194
2024 Q1 90.2M $2.15B +$44.6M $23.80 188
2023 Q4 87.6M $1.89B +$404M $21.61 176
2023 Q3 71M $1.03B -$1.24M $14.52 174
2023 Q2 70.6M $1.48B -$48.6M $20.93 164
2023 Q1 73M $1.54B +$23.6M $21.12 160
2022 Q4 71.4M $1.82B +$263M $25.45 157
2022 Q3 59.9M $1.44B +$95.5M $24.03 134
2022 Q2 55.2M $1.06B +$21.5M $19.24 117
2022 Q1 54.6M $948M -$36.4M $17.38 136
2021 Q4 52.4M $1.15B +$54.3M $21.89 130
2021 Q3 49.1M $938M -$20.7M $19.11 121
2021 Q2 50.2M $862M +$12.3M $17.17 113
2021 Q1 48.5M $1.08B +$46.5M $22.36 132
2020 Q4 46.5M $1.03B +$270M $22.24 142
2020 Q3 34.2M $505M +$23.5M $14.76 99
2020 Q2 32.6M $484M +$177M $14.82 98
2020 Q1 20.8M $228M +$45.4M $10.97 82
2019 Q4 16.7M $146M -$3.74M $8.78 71
2019 Q3 17.1M $128M -$812K $7.47 72
2019 Q2 17.2M $160M +$3.97M $9.31 72
2019 Q1 17M $89M +$8.09M $5.25 67
2018 Q4 15.5M $68.8M -$2.73M $4.45 73
2018 Q3 15.3M $124M +$3.41M $8.08 72
2018 Q2 15.1M $106M -$23.3M $7.02 83
2018 Q1 17.2M $244M +$5.18M $14.23 72
2017 Q4 17.2M $150M +$15.9M $8.76 76
2017 Q3 15M $176M -$8.29M $11.70 67
2017 Q2 15.7M $219M +$56.8M $13.97 65
2017 Q1 11.7M $160M +$30.2M $13.72 63
2016 Q4 11.1M $79.7M -$4.87M $7.17 54
2016 Q3 11.6M $176M +$19.9M $15.16 44
2016 Q2 10.3M $101M +$10.8M $9.85 46
2016 Q1 9.44M $126M +$126M $13.32 27